Sun Pharmaceutical Industries Stock Current Valuation
| SUNPHARMA | 1,734 15.20 0.87% |
Valuation analysis of Sun Pharmaceutical helps investors to measure Sun Pharmaceutical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Sun Pharmaceutical's Cash is relatively stable compared to the past year. As of 11/29/2024, Cash And Short Term Investments is likely to grow to about 203 B, while Begin Period Cash Flow is likely to drop slightly above 39.6 B. Fundamental drivers impacting Sun Pharmaceutical's valuation include:
Price Book 6.0732 | Enterprise Value 4 T | Enterprise Value Ebitda 25.6922 | Price Sales 8.2712 | Forward PE 26.9542 |
Overvalued
Today
Please note that Sun Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Sun Pharmaceutical is based on 3 months time horizon. Increasing Sun Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sun stock is determined by what a typical buyer is willing to pay for full or partial control of Sun Pharmaceutical Industries. Since Sun Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sun Stock. However, Sun Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1734.25 | Real 1537.56 | Hype 1734.25 | Naive 1740.34 |
The intrinsic value of Sun Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sun Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sun Pharmaceutical Industries helps investors to forecast how Sun stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sun Pharmaceutical more accurately as focusing exclusively on Sun Pharmaceutical's fundamentals will not take into account other important factors: Sun Pharmaceutical Industries Company Current Valuation Analysis
Sun Pharmaceutical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sun Pharmaceutical Current Valuation | 3.98 T |
Most of Sun Pharmaceutical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sun Pharmaceutical Industries is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sun Pharmaceutical Industries has a Current Valuation of 3.98 T. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Sun Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sun Pharmaceutical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sun Pharmaceutical could also be used in its relative valuation, which is a method of valuing Sun Pharmaceutical by comparing valuation metrics of similar companies.Sun Pharmaceutical is currently under evaluation in current valuation category among its peers.
Sun Pharmaceutical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sun Pharmaceutical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sun Pharmaceutical's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Sun Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0854 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 3.98 T | ||||
| Shares Outstanding | 2.4 B | ||||
| Shares Owned By Insiders | 55.10 % | ||||
| Shares Owned By Institutions | 26.31 % | ||||
| Price To Book | 6.07 X | ||||
| Price To Sales | 8.27 X | ||||
| Revenue | 477.58 B | ||||
| Gross Profit | 332.24 B | ||||
| EBITDA | 138.36 B | ||||
| Net Income | 95.76 B | ||||
| Cash And Equivalents | 13.87 B | ||||
| Total Debt | 32.74 B | ||||
| Book Value Per Share | 288.72 X | ||||
| Cash Flow From Operations | 121.35 B | ||||
| Earnings Per Share | 46.19 X | ||||
| Target Price | 2043.32 | ||||
| Number Of Employees | 43 K | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 4.16 T | ||||
| Total Asset | 854.63 B | ||||
| Retained Earnings | 501.55 B | ||||
| Working Capital | 264.91 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 854.63 B |
About Sun Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sun Pharmaceutical Industries's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sun Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sun Pharmaceutical Industries based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sun Stock Analysis
When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.